Abstract
Acute variceal bleeding (AVB) is one of the most common complications of liver cirrhosis with a high morbidity and mortality. Despite the improved management strategy, the mortality of patients with AVB is still very high. An adequate selection of high-risk patients could help to optimize the management strategy and further improve the outcomes. Many prognostic assessment methods of AVB in cirrhotic patients have been identified. In the present chapter, we briefly reviewed the prognostic assessment of AVB in patients with liver cirrhosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
De Franchis R. Portal hypertension VI: proceedings of the sixth Baveno consensus workshop: stratifying risk and individualizing care: Springer; 2015.
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362(9):823–32.
Abraldes JG, Bosch J. The treatment of acute variceal bleeding. J Clin Gastroenterol. 2007;41(Suppl 3):S312–7.
de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.
Singal AK, Jampana SC, Singal V, Kuo YF. Hepatocellular carcinoma predicts in-hospital mortality from acute variceal hemorrhage among patients with cirrhosis. J Clin Gastroenterol. 2012;46(7):613–9.
Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut. 2008;57(6):814–20.
Ibrahim M, Mostafa I, Deviere J. New developments in managing Variceal bleeding. Gastroenterology. 2018;154(7):1964–9.
Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58(1):45–50.
Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut. 2019;68(7):1297–310.
Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, et al. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol. 2016;10(8):971–80.
Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med. 2015;8(1):751–7.
Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95(8):e2877.
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71.
Flores-Rendon AR, Gonzalez-Gonzalez JA, Garcia-Compean D, Maldonado-Garza HJ, Garza-Galindo AA. Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding. Ann Hepatol. 2008;7(3):230–4.
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(Suppl(1)):S100–7.
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.
Wang R, Guo X, Fernando GR, Qi X. The optimal imaging diagnostic method of sarcopenia in liver transplantation: an unresolved issue. AME Med J. 2018;2:47.
Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–26.
Wang J, Wang AJ, Li BM, Liu ZJ, Chen L, Wang H, et al. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy. J Clin Gastroenterol. 2014;48(10):870–7.
Rout G, Sharma S, Gunjan D, Kedia S, Saraya A, Nayak B, et al. Development and validation of a novel model for outcomes in patients with cirrhosis and acute variceal bleeding. Dig Dis Sci. 2019;64(8):2327–37.
Cerqueira RM, Andrade L, Correia MR, Fernandes CD, Manso MC. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2012;24(5):551–7.
Child CG, Turcotte JG. The liver and portal hypertension. Philadelphia: MPCS. WB Saunders; 1964.
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.
Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology. 2002;35(5):1282–4.
Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215–24.
Wang F, Cui S, Wang F, Li F, Tang F, Zhang X, et al. Different scoring systems to predict 6-week mortality in cirrhosis patients with acute variceal bleeding: a retrospective analysis of 202 patients. Scand J Gastroenterol. 2018;53(7):885–90.
Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for uppergastrointestinal haemorrhage. Lancet. 2000;356(9238):1318–21.
Iino C, Shimoyama T, Igarashi T, Aihara T, Ishii K, Sakamoto J, et al. Usefulness of the Glasgow-Blatchford score to predict 1-week mortality in patients with esophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2017;29(5):547–51.
Lee HH, Park JM, Han S, Park SM, Kim HY, Oh JH, et al. A simplified prognostic model to predict mortality in patients with acute variceal bleeding. Dig Liver Dis. 2018;50(3):247–53.
D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–93.
Li Y, Han B, Li H, Song T, Bao W, Wang R, et al. Effect of admission time on the outcomes of liver cirrhosis with acute upper gastrointestinal bleeding: regular hours versus off-hours admission. Can J Gastroenterol Hepatol. 2018;2018:3541365.
Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–8.
Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Turk J Gastroenterol. 2016;27(2):180–6.
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30.
Qi X, Li J, Deng H, Li H, Su C, Guo X. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: a systematic review and meta-analysis of observational studies. Oncotarget. 2016;7(29):45283–301.
Peng Z, He Z, Guo X, Tacke F, Yang S-S, Sugawara Y, et al. Neutrophil to lymphocyte ratio and albumin-bilirubin score for predicting the in-hospital mortality of hepatocellular carcinoma with acute upper gastrointestinal bleeding. J AME Med J. 2017;2(11)
Bai Z, Li B, Lin S, Liu B, Li Y, Zhu Q, et al. Development and validation of CAGIB score for evaluating the prognosis of cirrhosis with acute gastrointestinal bleeding: a retrospective multicenter study. Adv Ther. 2019;36(11):3211–20.
Gao F, Wang R, Deng H, Hou F, Romeiro FG, Qi X. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis. Postgrad Med. 2017;129(7):756–61.
Deng H, Qi X, Zhang Y, Peng Y, Li J, Guo X. Diagnostic accuracy of contrast-enhanced computed tomography for esophageal varices in liver cirrhosis: a retrospective observational study. J Evid Based Med. 2017;10(1):46–52.
Li Q, Wang R, Guo X, Li H, Shao X, Zheng K, et al. Contrast-enhanced CT may be a diagnostic alternative for gastroesophageal varices in cirrhosis with and without previous endoscopic variceal therapy. Gastroenterol Res Pract. 2019;2019:6704673.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wang, R., Silva-Junior, G., Guo, X., Qi, X. (2021). Prognostic Assessment of Variceal Bleeding in Liver Cirrhosis. In: Guo, X., Qi, X. (eds) Variceal Bleeding in Liver Cirrhosis. Springer, Singapore. https://doi.org/10.1007/978-981-15-7249-4_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-7249-4_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7248-7
Online ISBN: 978-981-15-7249-4
eBook Packages: MedicineMedicine (R0)